home / stock / vvos / vvos articles
LITTLETON, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the "Company" or "Vivos") (NASDAQ:VVOS a leading medical technolog...
Vivos Executes Distribution Agreement with Established Dubai-based Sleep Testing Company Subject to Regulatory Approvals, Vivos Could See Revenue ...
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling over 50 points on Wednesday. The Dow traded down 0.24% to...
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Wednesday. The Dow traded up 0.28% to 33,094.01 wh...
Vivos Therapeutics Inc (NASDAQ: VVOS) announced two critical strategic agreements that will expand Vivos' current product line and are exp...
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 50 points on Wednesday. Following the market opening Wednesday, the Do...
LITTLETON, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the "Company" or "Vivos") (NASDAQ:VVOS), a leading medical device ...
News, Short Squeeze, Breakout and More Instantly...
Vivos Therapeutics Inc. Company Name:
VVOS Stock Symbol:
NASDAQ Market:
Vivos Therapeutics Inc. Website:
LITTLETON, Colo., June 27, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company” (NASDAQ:VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments f...
Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders (including all severities of obstructive sleep apnea (“OSA”) i...
Alliance with Sleep Treatment Provider in Colorado Marks Critical Pivot in Vivos’ Marketing and Distribution Model Aimed at Enhancing Revenue Streams and Potential Profit Private Placement Investment Sponsored by Seneca Partners, Who Will Also Provide General Management Advisory ...